ERAS Deadline Alert: Levi & Korsinsky Reminds Erasca, Inc. (ERAS) Investors of Securities Class Action Deadline on August 10, 2026
Erasca Allegedly Concealed Patent Infringement Risk and a Patient Death While Publicly Promoting ERAS-0015 as a "Best-in-Class" Drug Candidate, Costing Investors $11.59 Per Share NEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Erasca, Inc. (NASDAQ:...
Erasca Allegedly Concealed Patent Infringement Risk and a Patient Death While Publicly Promoting ERAS-0015 as a "Best-in-Class" Drug Candidate, Costing Investors $11.59 Per Share NEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Erasca, Inc. (NASDAQ:...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.